F074 Medical and Surgical Management of Nail Disorders
DESCRIPTION
Learn from world-renowned nail specialists how to expertly and efficiently manage some of the most common nail disorders that present to dermatology. You will learn their top tips for optimizing patient care outcomes that you can immediately use in your practice.
LEARNING OBJECTIVES
Recognize clinical settings in which nail disorders necessitate ancillary testing e.g. imaging, nail clippings, biopsy to inform therapeutic options.
Develop a treatment approach(es) for a variety of common inflammatory, infectious, and neoplastic nail disorders in children and adults.
DIRECTOR
Molly A. Hinshaw, MD, FAAD
SPEAKERS
Shari Lipner, MD, PhD, FAAD
Beth McLellan, MD, FAAD
Julie Mervak, MD, FAAD
Brian William Morrison, MD, MSc, FAAD
Bianca Maria Piraccini, MD, IFAAD
Phoebe Rich, MD, FAAD
Andrea Sechi
Tracey C. Vlahovic, DPM
HANDOUTS
DISCLOSURES
Molly A. Hinshaw, MD, FAAD
BiaCure Therapies Inc – Founder(Stock); Elucent Medical – Stockholder Private Company(No Compensation Received); RevOps – Stockholder Private Company(No Compensation Received);
Shari Lipner, MD, PhD, FAAD
Veradermics – Advisory Board(Honoraria);
Beth McLellan, MD, FAAD
Bristol Myers Squibb – Investigator(Grants/Research Funding); Hoth Therapeutics – Investigator(Grants/Research Funding); Kintara Therapeutics, Inc. – Investigator(Grants/Research Funding); OnQuality Pharmaceuticals, Ltd. – Investigator(Grants/Research Funding); Paula's Choice – Advisory Board(Honoraria); Paxman – Investigator(Equipment); Pfizer Inc. – Other(Grants/Research Funding); RBC Consultants – Advisory Board(Honoraria); Spruce – Advisory Board(Stock Options); UpToDate – Other(Fees);
Julie Mervak, MD, FAAD
No financial relationships exist with ineligible companies.
Brian William Morrison, MD, MSc, FAAD
No financial relationships exist with ineligible companies.
Bianca Maria Piraccini, MD, IFAAD
Difa Cooper – Consultant (1099 relationship)(Honoraria); Eli Lilly – Advisory Board(Fees); Giuliani Pharma – Consultant (1099 relationship)(Honoraria); L'Oréal France – Advisory Board(Fees); Pfizer Inc. – Consultant (1099 relationship)(Honoraria); Pierre Fabre Dermo Cosmetique France – Advisory Board(Fees);
Phoebe Rich, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Alfasigma Global – Investigator(Grants/Research Funding); Allakos – Investigator(Grants/Research Funding); Amgen – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Cara Therapeutics – Advisory Board(Honoraria); Dermavant Sciences – Investigator(Grants/Research Funding); DermBiont – Investigator(Grants/Research Funding); Dermira – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding); Hallux, Inc. – Investigator(Grants/Research Funding); Hexima Ltd. – Investigator(Grants/Research Funding); Incyte – Investigator(Grants/Research Funding); Janssen Biotech – Investigator(Grants/Research Funding); Janssen-Ortho Inc. – Investigator(Grants/Research Funding); L'Oreal – Investigator(Grants/Research Funding); La Roche Posay Dermatologique – Advisory Board(Honoraria); Leo Pharma Inc – Investigator(Grants/Research Funding); Moberg Derma – Investigator(Grants/Research Funding); Oruka Therapeutics – Advisory Board(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); Technoderma Medicines – Investigator(Grants/Research Funding); UCB – Investigator(Grants/Research Funding);
Andrea Sechi
No financial relationships exist with ineligible companies.
Tracey C. Vlahovic, DPM
Valeant Pharmaceuticals North America LLC – Investigator(No Compensation Received);